Cost-effectiveness of Aflibercept vs Bevacizumab-First Therapy for Diabetic Macular Edema
Listen now
Description
Interview with David W. Hutton, PhD, author of Cost-effectiveness of Aflibercept Monotherapy vs Bevacizumab First Followed by Aflibercept If Needed for Diabetic Macular Edema. Hosted by Neil Bressler, MD.
More Episodes
Interview with Joseph F. Rizzo III, MD, author of Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide. Hosted by Neil M. Bressler, MD.
Related Content:
Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide
Published 08/15/24
Interview with Gerami D. Seitzman, MD, author of Biomarker Detection and Validation for Corneal Involvement in Patients With Acute Infectious Conjunctivitis. Hosted by Neil Bressler, MD.
Related Content:
Biomarker Detection and Validation for Corneal Involvement in Patients With Acute...
Published 08/15/24
Published 08/15/24
Links
Genres
Artwork or description wrong?
Request an update »
Updates may take a few minutes.
Do you host a podcast?
Track your ranks and reviews from Spotify, Apple Podcasts and more.
See hourly chart positions and more than 30 days of history.
Get Chartable Analytics »
See hourly chart positions and more than 30 days of history.
